Status:
WITHDRAWN
Endometriosis: Immunomodulation
Lead Sponsor:
University of Wisconsin, Madison
Conditions:
Endometriosis
Eligibility:
FEMALE
18-45 years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to compare the effect of pioglitazone versus no drug on soluble profinflammatory markers in peritoneal fluid of women with endometriosis.
Detailed Description
The overall goal of this proposal is to assess modulation of immune mechanisms in endometriosis. Endometriosis is a common ailment affecting approximately five million reproductive-aged American women...
Eligibility Criteria
Inclusion
- Healthy woman age 18 - 45 years.
- Regular cycles (24-35 days).
- Pelvic pain ≥ 3 months.
- Negative pregnancy test.
- Non-lactating.
- No prior (\<3 months) use of hormonal therapy.
- No history of liver disease.
- Suspected endometriosis and scheduled for surgery to confirm this diagnosis
- Surgery scheduled in follicular phase.
- Consent to participate in the study.
- Enrollment into data analysis portion of study if:
- Endometriosis diagnosed from surgical specimen by routine hematoxylin and eosin staining and histological evaluation.
Exclusion
- Major psychiatric conditions or the abuse of alcohol or drugs which would make it difficult for the subject to complete study procedures.
- Active or prior infection with hepatitis, human immunodeficiency virus (HIV) infection, or history of high-risk activities (e.g., IV drug abuse) which would increase risk to laboratory personnel. Of note, no testing for hepatitis or HIV will be performed as part of this study and all tissues will be handled and discarded as if they were potentially infected.
- Patients with liver dysfunction (elevated liver enzymes \> 2 times the upper limit of normal).
- Presence of pre-existing malignancy, including carcinoma of the breast or uterus.
- Women with other causes of chronic pelvic pain including infectious, gastrointestinal, musculoskeletal, neurologic or psychiatric.
- Elevated WBC.
- NYHA functional class I-IV heart failure.
- Diabetes mellitus.
- Known pregnancy or positive pregnancy test.
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2012
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01184144
Start Date
August 1 2010
End Date
May 1 2012
Last Update
October 2 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.